Diphencyprone as a therapeutic option in cutaneous metastasis of melanoma. A single-institution experience
Abstract: Diphencyprone has been reported as a local immunotherapy for cutaneous melanoma metastases. We aim to report cases of melanoma patients treated with diphencyprone in a single Brazilian institution and highlight their outcomes. Since 2012, we have treated 16 melanoma patients with cutaneous...
Saved in:
Main Authors: | Ivana Lameiras Gibbons (Author), Marina Sonagli (Author), Eduardo Bertolli (Author), Mariana Petaccia de Macedo (Author), Clovis Antonio Lopes Pinto (Author), João Pedreira Duprat Neto (Author) |
---|---|
Format: | Book |
Published: |
Sociedade Brasileira de Dermatologia,
2018-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vemurafenib and cutaneous adverse events - report of five cases
by: Giselle de Barros Silva, et al.
Published: (2015) -
How does the mitotic index impact patients with T1 melanoma? Comparison between the 7th and 8th edition of the American Joint Committee on Cancer melanoma staging system,
by: Amanda Zorzetto Antonialli, et al.
Published: (2020) -
Intraoperative assessment of surgical margins using ‟en face" frozen sections in the management of cutaneous carcinomas
by: Ana Carolina Vasconcellos Guedes Otsuka, et al.
Published: (2022) -
Skin proteomic analysis of immune activation associated with regression of melanoma metastases induced by diphencyprone
by: Joseph Han, BS, et al.
Published: (2022) -
Vitiligo after Diphencyprone for Alopecia Areata
by: Mario Cezar Pires, et al.
Published: (2010)